Showing 1331-1340 of 1697 results for "".
- In Utero Exposure to Ocrevus Not Associated with Elevated Adverse Outcomes in Pregnancyhttps://practicalneurology.com/news/in-utero-exposure-to-ocrevus-not-associated-with-elevated-adverse-outcomes-in-pregnancy/2470314/In a study of the largest available dataset for pregnancy outcomes for an anti-CD20 monoclonal antibody therapy, in utero exposure to Ocrevus (ocrelizumab; Genentech, South San Francisco, CA), a medication used to treat multiple sclerosis (MS), was not associated with an elevated risk of preterm
- Vaccinations Not Associated with Multiple Sclerosis Flare-ups According to New Studyhttps://practicalneurology.com/news/vaccinations-not-associated-with-multiple-sclerosis-flare-ups-according-to-new-study/2470300/According to results from a nationwide French study published in JAMA Neurology, there was no association between vaccinations and incidence of severe multiple sclerosis (MS) flare-ups requiring hospitalization. The findings were consistent regardless of age range, whether the participan
- Researchers Confirm 4 Genes Associated with Increased Risk of Developing PMLhttps://practicalneurology.com/news/researchers-confirm-4-genes-associated-with-an-increased-risk-of-developing-pml-researchers-confirm-4-genes-associated-with-an-increased-risk-of-developing-pml/2470291/Researchers have identified 4 genes associated with an increased risk of developing progressive multifocal leukoencephalopathy (PML) in patients taking 99 different PML-linked drugs for a variety of conditions, including multiple sclerosis (MS), blood cancers, and rheumatoid arthritis. This study
- Muscular Dystrophy Association Announces the Start of 30 Days of Strength Campaignhttps://practicalneurology.com/news/mda-announces-the-start-of-30-days-of-strength-campaign/2470289/The Muscular Dystrophy Association (MDA) has announced the start of its 30 Days of Strength campaign for September, which is National Muscular Dystrophy Awareness Month. Throughout the month, the MDA will collaborate with influencers and community leaders, including Nyheim Hines, running back for
- New FDA Filing for Potential Drug To Treat Chorea Associated with Huntington Diseasehttps://practicalneurology.com/news/new-fda-filing-for-potential-drug-to-treat-chorea-associated-with-huntington-disease/2470090/The Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for valbenazine (Ingrezza; Neurocrine Biosciences, San Diego, CA) as a treatment for chorea associated with Huntington disease (HD). The sNDA filing contained data from the KINECT-HD phase 3 study (
- American Heart Association Releases Statement on Cannabis and Brain Healthhttps://practicalneurology.com/news/american-heart-association-releases-statement-on-cannabis-and-brain-health/2469820/A new American Heart Association (AHA) scientific statement published in Stroke states that although there is a perception that cannabis is harmless, there is some scientific evidence challenging that belief. The statement also notes there are many unanswered questions about its impact on brain h
- Clinical Implications of Pimavanserin Association With Mortality in Parkinson Disease Psychosishttps://practicalneurology.com/news/clinical-implications-of-pimavanserin-association-with-mortality-in-parkinson-disease-psychosis/2469708/It has been suggested that use of pimavanserin for the treatment of Parkinson disease (PD) psychosis symptoms is associated with higher mortality rates. The FDA found these rates unsimilar to that seen with other atypical antipsychotics, and both carry a black-box warning as a result. This has be
- Poor Sleep Associated With Long-Term Cognitive Decline in Hispanic/Latinxhttps://practicalneurology.com/news/poor-sleep-associated-with-long-term-cognitive-decline-in-hispaniclatinx/2469602/According to research led by University of Miami Miller School of Medicine neurology faculty, poor sleep is associated with the risk of long-term cognitive decline in Hispanic/Latinx adults. A paper published online on May 25, 2021 in Alzheimer & Dementia reported the risk was
- Higher Risks for Alzheimer Disease Associated With Living in Poorer Areashttps://practicalneurology.com/news/higher-risks-for-alzheimer-disease-associated-with-living-in-poorer-areas/2469553/According to a study in Neurology, individuals living in areas with higher poverty levels and fewer opportunities had more atrophy on brain scans and showed faster decline on cognitive tests, both associated with risk of Alzheimer disease (AD). In this longitudinal study, individuals with a
- Using Cannabis for Migraine Relief May Be Associated With Medication-Adaptation Headachehttps://practicalneurology.com/news/using-cannabis-for-migraine-relief-may-be-associated-with-medication-adaptation-headache/2469519/A preliminary study found that using cannabis for relief from migraine headache may be associated with medication-adaptation headache (MAH; also called medication-overuse headache). The records of 368 people who had chronic migraine (15 or more headache days per month) for at leas